Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · IEX Real-Time Price · USD
0.357
+0.017 (5.03%)
At close: Apr 24, 2024, 4:00 PM
0.348
-0.009 (-2.47%)
After-hours: Apr 24, 2024, 7:54 PM EDT
Dermata Therapeutics Stock Forecast
Stock Price Forecast
There is currently no analyst price target forecast available for DRMA.
Analyst Consensus: n/a
Analyst Ratings
There are currently no analyst ratings available for DRMA.
Recommendation Trends
| Rating | Dec '22 | Jan '23 | Feb '23 | Mar '23 |
|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 0 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 0 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy Maintains $16 → $4 | Strong Buy | Maintains | $16 → $4 | +1,021.08% | Mar 23, 2023 |
| Brookline Capital | Brookline Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 21, 2021 |
| Maxim Group | Maxim Group | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Sep 14, 2021 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.41
from -2.67
EPS Next Year
-0.67
from -1.41
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.45 | -0.69 | -0.59 |
| Avg | -1.41 | -0.67 | -0.57 |
| Low | -1.35 | -0.65 | -0.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.